Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue and Organ Procurement | 18 | 2024 | 347 | 8.640 |
Why?
|
| Heart Transplantation | 17 | 2024 | 717 | 7.840 |
Why?
|
| Waiting Lists | 14 | 2023 | 184 | 4.100 |
Why?
|
| Registries | 11 | 2024 | 784 | 3.570 |
Why?
|
| Heart Failure | 8 | 2024 | 1185 | 2.860 |
Why?
|
| Tissue Donors | 11 | 2024 | 494 | 2.450 |
Why?
|
| Graft Survival | 5 | 2024 | 900 | 2.130 |
Why?
|
| Kidney Transplantation | 5 | 2024 | 850 | 1.970 |
Why?
|
| Resource Allocation | 5 | 2023 | 65 | 1.820 |
Why?
|
| Transplant Recipients | 5 | 2023 | 137 | 1.800 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 182 | 1.430 |
Why?
|
| Intensive Care Units | 4 | 2021 | 396 | 1.360 |
Why?
|
| United States | 20 | 2024 | 6987 | 1.340 |
Why?
|
| Lung Transplantation | 3 | 2024 | 292 | 1.260 |
Why?
|
| Humans | 57 | 2024 | 89349 | 1.120 |
Why?
|
| Liver Transplantation | 3 | 2023 | 1180 | 1.100 |
Why?
|
| Ventilators, Mechanical | 3 | 2021 | 37 | 1.080 |
Why?
|
| Resuscitation Orders | 2 | 2023 | 65 | 1.070 |
Why?
|
| Vaccination | 3 | 2022 | 274 | 1.040 |
Why?
|
| Health Care Rationing | 4 | 2024 | 83 | 1.000 |
Why?
|
| Organ Dysfunction Scores | 3 | 2022 | 27 | 0.990 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 319 | 0.990 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 304 | 0.980 |
Why?
|
| Organ Preservation | 2 | 2024 | 106 | 0.930 |
Why?
|
| Standard of Care | 2 | 2022 | 65 | 0.930 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1046 | 0.910 |
Why?
|
| Hospital Mortality | 4 | 2021 | 387 | 0.850 |
Why?
|
| Perfusion | 1 | 2024 | 236 | 0.850 |
Why?
|
| End Stage Liver Disease | 1 | 2023 | 60 | 0.840 |
Why?
|
| Professional-Family Relations | 2 | 2020 | 54 | 0.820 |
Why?
|
| Male | 27 | 2024 | 42410 | 0.810 |
Why?
|
| Bioethics | 1 | 2022 | 35 | 0.810 |
Why?
|
| Acute-On-Chronic Liver Failure | 1 | 2021 | 4 | 0.800 |
Why?
|
| Retrospective Studies | 14 | 2024 | 9057 | 0.790 |
Why?
|
| Adult | 19 | 2024 | 26607 | 0.780 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 39 | 0.780 |
Why?
|
| Preoperative Care | 1 | 2023 | 396 | 0.760 |
Why?
|
| Female | 27 | 2024 | 46200 | 0.760 |
Why?
|
| Medical Overuse | 2 | 2018 | 36 | 0.760 |
Why?
|
| Vaccines | 1 | 2022 | 83 | 0.760 |
Why?
|
| Cardiotonic Agents | 2 | 2020 | 89 | 0.740 |
Why?
|
| Medical Futility | 1 | 2020 | 31 | 0.730 |
Why?
|
| Middle Aged | 19 | 2024 | 25974 | 0.730 |
Why?
|
| Betacoronavirus | 2 | 2020 | 261 | 0.710 |
Why?
|
| Patient Selection | 3 | 2021 | 684 | 0.700 |
Why?
|
| Pandemics | 6 | 2023 | 773 | 0.680 |
Why?
|
| Emergencies | 1 | 2020 | 121 | 0.680 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 420 | 0.640 |
Why?
|
| Critical Illness | 4 | 2021 | 306 | 0.630 |
Why?
|
| Lithium Compounds | 1 | 2018 | 9 | 0.630 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 1714 | 0.630 |
Why?
|
| Groundwater | 1 | 2018 | 11 | 0.630 |
Why?
|
| Kidney Failure, Chronic | 2 | 2024 | 414 | 0.620 |
Why?
|
| Delayed Graft Function | 1 | 2018 | 13 | 0.620 |
Why?
|
| Survival Rate | 6 | 2024 | 1901 | 0.610 |
Why?
|
| Policy | 3 | 2023 | 35 | 0.600 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 352 | 0.580 |
Why?
|
| Prognosis | 4 | 2023 | 3783 | 0.580 |
Why?
|
| Informed Consent | 1 | 2020 | 275 | 0.580 |
Why?
|
| Family | 1 | 2019 | 325 | 0.570 |
Why?
|
| Organ Transplantation | 1 | 2020 | 276 | 0.540 |
Why?
|
| Dementia | 1 | 2018 | 194 | 0.540 |
Why?
|
| Time Factors | 6 | 2024 | 5337 | 0.540 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 106 | 0.530 |
Why?
|
| Heart | 4 | 2024 | 573 | 0.530 |
Why?
|
| Physicians | 2 | 2020 | 690 | 0.520 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 387 | 0.510 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 757 | 0.490 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 851 | 0.480 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 3666 | 0.470 |
Why?
|
| Death | 2 | 2024 | 85 | 0.440 |
Why?
|
| Risk Factors | 6 | 2024 | 5498 | 0.410 |
Why?
|
| Graft Rejection | 1 | 2018 | 1070 | 0.400 |
Why?
|
| Cohort Studies | 6 | 2024 | 2869 | 0.390 |
Why?
|
| Child | 6 | 2024 | 7173 | 0.370 |
Why?
|
| Withholding Treatment | 2 | 2024 | 117 | 0.370 |
Why?
|
| Hospitalization | 3 | 2024 | 877 | 0.340 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 1840 | 0.310 |
Why?
|
| Aged | 9 | 2024 | 19165 | 0.300 |
Why?
|
| Critical Care | 2 | 2021 | 382 | 0.300 |
Why?
|
| Postoperative Complications | 1 | 2018 | 2284 | 0.290 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2623 | 0.280 |
Why?
|
| Child, Preschool | 3 | 2024 | 3731 | 0.260 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 4 | 0.240 |
Why?
|
| Illinois | 2 | 2024 | 480 | 0.230 |
Why?
|
| Early Diagnosis | 1 | 2024 | 125 | 0.230 |
Why?
|
| Longevity | 1 | 2024 | 58 | 0.230 |
Why?
|
| Bilirubin | 1 | 2024 | 131 | 0.230 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2024 | 53 | 0.230 |
Why?
|
| Donor Selection | 1 | 2024 | 74 | 0.220 |
Why?
|
| Life Support Care | 1 | 2024 | 50 | 0.220 |
Why?
|
| Risk Assessment | 2 | 2024 | 2303 | 0.220 |
Why?
|
| Organ Size | 1 | 2024 | 371 | 0.220 |
Why?
|
| Thermodilution | 1 | 2022 | 21 | 0.210 |
Why?
|
| Advisory Committees | 1 | 2022 | 89 | 0.200 |
Why?
|
| Hypothermia | 1 | 2022 | 26 | 0.200 |
Why?
|
| Machine Learning | 1 | 2024 | 258 | 0.200 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 2021 | 6 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 112 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2024 | 860 | 0.200 |
Why?
|
| Body Temperature | 1 | 2022 | 125 | 0.200 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 56 | 0.190 |
Why?
|
| Norepinephrine | 1 | 2021 | 172 | 0.190 |
Why?
|
| Oxygen Consumption | 1 | 2022 | 244 | 0.190 |
Why?
|
| Inpatients | 1 | 2024 | 310 | 0.190 |
Why?
|
| Triage | 1 | 2021 | 111 | 0.190 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 53 | 0.180 |
Why?
|
| Treatment Outcome | 2 | 2024 | 8241 | 0.180 |
Why?
|
| Chicago | 2 | 2022 | 1427 | 0.180 |
Why?
|
| Third-Party Consent | 1 | 2020 | 24 | 0.180 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 20 | 0.180 |
Why?
|
| Proxy | 1 | 2020 | 26 | 0.180 |
Why?
|
| Coronavirus | 1 | 2020 | 18 | 0.180 |
Why?
|
| Ownership | 1 | 2020 | 26 | 0.180 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 91 | 0.170 |
Why?
|
| Research Design | 1 | 2023 | 599 | 0.170 |
Why?
|
| Patient Acuity | 1 | 2019 | 33 | 0.170 |
Why?
|
| Adolescent | 3 | 2024 | 9263 | 0.170 |
Why?
|
| Quality of Health Care | 2 | 2020 | 385 | 0.170 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2020 | 78 | 0.170 |
Why?
|
| Acute Disease | 1 | 2021 | 841 | 0.170 |
Why?
|
| Morals | 1 | 2020 | 94 | 0.170 |
Why?
|
| Social Justice | 1 | 2020 | 54 | 0.170 |
Why?
|
| Age Factors | 1 | 2024 | 1870 | 0.170 |
Why?
|
| Trust | 1 | 2020 | 98 | 0.170 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 1723 | 0.160 |
Why?
|
| Public Health | 1 | 2020 | 138 | 0.160 |
Why?
|
| Prevalence | 2 | 2024 | 1243 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2020 | 231 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2020 | 188 | 0.160 |
Why?
|
| Decision Making | 2 | 2024 | 667 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 202 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 114 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2024 | 4289 | 0.150 |
Why?
|
| Health Resources | 1 | 2018 | 81 | 0.150 |
Why?
|
| Propensity Score | 1 | 2018 | 147 | 0.150 |
Why?
|
| Logistic Models | 1 | 2021 | 1213 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 838 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 669 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 275 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2019 | 1534 | 0.130 |
Why?
|
| Pediatrics | 1 | 2020 | 353 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 1194 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2020 | 410 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 645 | 0.130 |
Why?
|
| Communication | 1 | 2019 | 459 | 0.130 |
Why?
|
| Infant | 1 | 2022 | 3157 | 0.130 |
Why?
|
| Phenotype | 1 | 2022 | 2440 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2758 | 0.120 |
Why?
|
| Algorithms | 1 | 2021 | 1877 | 0.110 |
Why?
|
| Young Adult | 1 | 2024 | 6312 | 0.100 |
Why?
|
| Hepatectomy | 1 | 2013 | 170 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6811 | 0.090 |
Why?
|
| Living Donors | 1 | 2013 | 339 | 0.090 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 24 | 0.060 |
Why?
|
| Actigraphy | 1 | 2024 | 59 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2024 | 337 | 0.060 |
Why?
|
| Nomograms | 1 | 2023 | 29 | 0.050 |
Why?
|
| Thorax | 1 | 2023 | 77 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 781 | 0.050 |
Why?
|
| Cardiac Output | 1 | 2022 | 156 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2022 | 92 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2021 | 157 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 186 | 0.050 |
Why?
|
| Hospitals | 1 | 2024 | 299 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 164 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2024 | 352 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2022 | 344 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 377 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 385 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 345 | 0.040 |
Why?
|
| Racism | 1 | 2020 | 89 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 787 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 588 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 435 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 949 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2023 | 2018 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 743 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 1097 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1595 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 428 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 972 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1767 | 0.030 |
Why?
|
| Morbidity | 1 | 2013 | 149 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 657 | 0.020 |
Why?
|